SFX by Ex Libris Inc.

Title:	A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice
Source:	Human Molecular Genetics [0964-6906] Porter, J D yr:2002

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Spencer, M J J. "Do immune cells promote the pathology of dystrophin-deficient myopathies?." Neuromuscular Disorders 11.6-7 (2001): 556-64.
description	2.	Askanas, V. "Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis." Current opinion in rheumatology 19.6 (2007): 550-9.
description	3.	Gussoni, E. "Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy." The journal of immunology 153.10 (1994): 4798-805.
description	4.	Rando, T A A. "The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies." Muscle & nerve 24.12: 1575-1594.
description	5.	Turk, R. "Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling." BMC genomics 6.1 (2005): 98-98.
description	6.	Askanas, V. "Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition." Neurology 66.2 Suppl 1 (2005): 39-48.
description	7.	Jennekens, F G I G. "[The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis']." Nederlands tijdschrift voor geneeskunde 149.38 (2005): 2104-11.
description	8.	Mastaglia, Merrilee L. "Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches." Lancet. Neurology 6.7 (2007): 620-31.
description	9.	del Gaudio, Daniela D. "Regional genomic instability predisposes to complex dystrophin gene rearrangements." Human Genetics 126.3 (2009): 411-423.
description	10.	Spencer, M J J. "Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle." Clinical immunology 98.2 (2001): 235-43.
description	11.	Ambros, V. "The functions of animal microRNAs." Nature 431.7006 (2004): 350-355.
description	12.	Dalakas, Marinos C C. "Inflammatory, immune, and viral aspects of inclusion-body myositis." Neurology 66.2 (2005): -8.
description	13.	Dalakas, Marinos C C. "Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis." Current opinion in neurology 17.5 (2004): 561-7.
description	14.	Tidball, James G G. "Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis." Current opinion in rheumatology 17.6: 707-713.
description	15.	KORMAN, SH. "OROCECAL TRANSIT-TIME IN DUCHENNE MUSCULAR-DYSTROPHY." Archives of disease in childhood 66.1 (1991): 2-2.
description	16.	Villalta, Chiara A. "Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype." Human molecular genetics 20.4 (2011): 790-805.
description	17.	Bornstein, N M M. "Increased platelet aggregation and release reaction in myotonic dystrophy." Journal of the Neurological Sciences 84.2-3 (1988): 239-46.
description	18.	Turk, R. "Common and distinct gene expression patterns in mouse models for muscular dystrophies." Neuromuscular disorders 14.8-9 (2004): 609-609.
description	19.	Gosselin, Luc E E. "Impact of TNF-alpha blockade on TGF-beta1 and type I collagen mRNA expression in dystrophic muscle." Muscle & nerve (2004): 244-6.
description	20.	Pastoret, C. "Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse." Muscle & nerve 18.10 (1995): 1147-54.